Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01578577 · ClinicalTrials.gov registry record · NA
Northwestern University and Access Community Health Network Medication Education Study
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 920
- Enrollment target
NCT01578577: Completed NA study, sponsored by Northwestern University.
NCT01578577 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 920 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01578577, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 920 participants
- Enrollment target
Study Summary
Many patients have difficulty performing routine medication management tasks. Individuals with limited literacy are at high risk for these problems. The overall study objective is to rigorously evaluate two primary care-based medication therapy management strategies that leverage an electronic health record (EHR) to promote patient understanding, medication reconciliation, medication adherence and disease control among hypertensive patients at safety net clinics.
Primary Outcome
The primary outcome is the systolic blood pressure measured approximately one year after the baseline interview is conducted.
Interventions
- BEHAVIORAL EHMI
- BEHAVIORAL Nurse Educator + EHMI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 920 participants |
| Start Date | 2012-04 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT01578577 record still lists
NCT01578577 is an interventional study that assigns participants to a tested intervention. The registered 920 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 2 interventions - of which EHMI is the first listed.
NCT01578577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01578577 about?
NCT01578577 is a clinical study titled "Northwestern University and Access Community Health Network Medication Education Study". Many patients have difficulty performing routine medication management tasks. Individuals with limited literacy are at high risk for these problems. The overall study objective is to rigorously evaluate two primary care-based medication therapy management strategies that leverage an electronic healt...
What is the current status of trial NCT01578577?
This trial is currently completed. It is a NA study. The enrollment target is 920 participants. The study started on 2012-04. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01578577?
The interventions under investigation include: EHMI (BEHAVIORAL), Nurse Educator + EHMI (BEHAVIORAL).
Who is sponsoring clinical trial NCT01578577?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01578577's enrollment target sits among peer trials
920 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04589845 · 920 participants · Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- NCT06109870 · 920 participants · NA
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
- NCT06957366 · 920 participants · NA
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
- NCT07174336 · 920 participants · Phase 3
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia